Early intervention in the management of pulmonary arterial hypertension: clinical and economic outcomes
Charles D Burger,1 Mohamedanwar Ghandour,1 Divya Padmanabhan Menon,2 Haytham Helmi,3 Raymond L Benza4 1Division of Pulmonary, Allergy and Sleep Medicine, Mayo Clinic, 2Department of Internal Medicine, Mayo Clinic, 3Division of Transplant Medicine and Research Administration, Mayo Clinic, Jacksonvill...
Saved in:
Main Authors: | Burger CD (Author), Ghandour M (Author), Padmanabhan Menon D (Author), Helmi H (Author), Benza RL (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety, efficacy, and clinical utility of macitentan in the treatment of pulmonary arterial hypertension
by: Monaco TJ, et al.
Published: (2016) -
Economic evaluation of sildenafil for the treatment of pulmonary arterial hypertension in Indonesia
by: Oktavia Lilyasari, et al.
Published: (2019) -
Prostanoid therapies in the management of pulmonary arterial hypertension
by: LeVarge BL
Published: (2015) -
Safety and tolerability of bosentan in the management of pulmonary arterial hypertension
by: Kari E Roberts, et al.
Published: (2009) -
Pharmacogenomics in the Management of Pulmonary Arterial Hypertension: Current Perspectives
by: Coons JC, et al.
Published: (2023)